Hochschulschrift
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
- Weitere Titel
-
Die Tumorvasulatur in der erfolgreichen Therapie von Carcinomen durch onkolytische Vaccinia Viren
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Würzburg, Universität Würzburg, Dissertation, 2015
- Schlagwort
-
Vaccinia-Virus
Onkolyse
Angiogenese
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2015
- Urheber
- Beteiligte Personen und Organisationen
-
Szalay, A. A.
- URN
-
urn:nbn:de:bvb:20-opus-119019
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Gnamlin, Prisca
- Szalay, A. A.
- Universität Würzburg
Entstanden
- 2015
Ähnliche Objekte (12)
Use of tumor vasculature for successful treatment of carcinomas by oncolytic vaccinia virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Cellular factors contributing to host cell permissiveness in support of oncolytic vaccinia virus replication
Use of tumor vasculature for successful treatment of carcinomas by oncolytic vaccinia virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Cellular factors contributing to host cell permissiveness in support of oncolytic vaccinia virus replication
Use of tumor vasculature for successful treatment of carcinomas by oncolytic vaccinia virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication